Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reiferon Retard in Chronic Hepatitis C
NCT01649245Phase 4Unknown
- Sponsor
- Minapharm Pharmaceuticals
- Start
- Aug 2012
- Primary completion
- Aug 2014
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a in hepatitis C (HCV), sponsored by Minapharm Pharmaceuticals. Status: unknown.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01649245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01649245.